SCHEMBL14877386

SCHEMBL14877386

O=c1nc(-c2cccc3ccccc23)[nH]c2ccc(N3CCOCC3)cc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKDC P78527 7/20 0.54
▸ PIK3CD O00329 4/20 0.54
▸ PIK3CB P42338 4/20 0.54
▸ KIF11 P52732 4/20 0.51
▸ FGFR1 P11362 2/20 0.51
▸ FLT1 P17948 2/20 0.51
▸ PDGFRB P09619 1/20 0.51
▸ KDR P35968 1/20 0.51
▸ TDO2 P48775 1/20 0.47
▸ IDO2 Q6ZQW0 1/20 0.47
▸ PIK3CA P42336 2/20 0.46
▸ PIK3CG P48736 1/20 0.46
▸ XRCC6 P12956 1/20 0.46
▸ XRCC5 P13010 1/20 0.46
▸ CBFB Q13951 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ HPGD P15428 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14877134 0.90 KIF11 (0.47) PRKDCPIK3CDPIK3CBKIF11FGFR1
SCHEMBL14877438 0.89 KIF11 (0.49) PRKDCPIK3CDPIK3CBKIF11FGFR1
SCHEMBL14877399 0.85 PDGFRB (0.56) KIF11FGFR1FLT1PDGFRBKDR
SCHEMBL14877217 0.83 PRKDC (0.48) PRKDCPIK3CDPIK3CBKIF11FGFR1
SCHEMBL14877387 0.83 FGFR1 (0.53) PRKDCPIK3CDPIK3CBKIF11FGFR1
SCHEMBL7668851 0.77 KDM4E (0.58) PRKDCPIK3CDKIF11PIK3CAKDM4E
SCHEMBL14877015 0.75 KIF11 (0.46) KIF11FGFR1FLT1PDGFRBKDR
SCHEMBL14877166 0.74 KIF11 (0.47) KIF11FGFR1FLT1PDGFRBKDR
SCHEMBL14876948 0.73 KIF11 (0.44) PRKDCKIF11FGFR1FLT1PDGFRB
SCHEMBL15389029 0.72 KIF11 (0.46) PRKDCKIF11FGFR1PDGFRBKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9045437-B2 2-aryl-4-quinazolinones and their pharmaceutical compositions CHINA MEDICAL UNIVERSITY (TW) 2015-06-02 — — US disclosed
US-9006239-B2 2-aryl-4-quinazolinones and their pharmaceutical compositions CHINA MEDICAL UNIVERSITY (TW) 2015-04-14 — — US disclosed
US-8710064-B2 2-aryl-4-quinazolinones and their pharmaceutical compositions CHINA MEDICAL UNIVERSITY (TW) 2014-04-29 — — US disclosed
US-20140018363-A1 2-ARYL-4-QUINAZOLINONES AND THEIR PHARMACEUTICAL COMPOSITIONS CHINA MEDICAL UNIVERSITY (TW) 2014-01-16 — — US disclosed
US-20130310376-A1 2-ARYL-4-QUINAZOLINONES AND THEIR PHARMACEUTICAL COMPOSITIONS CHINA MEDICAL UNIVERSITY (TW) 2013-11-21 — — US disclosed
US-20130102602-A1 2-Aryl-4-Quinazolinones And Their Pharmaceutical Compositions CHINA MEDICAL UNIVERSITY (TW) 2013-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130102602-A1 2-Aryl-4-Quinazolinones And Their Pharmaceutical Compositions AQP4, KRAS, RB1 PRKDC 4606/4885PIK3CD 2974/4885PIK3CB 3362/4885
US-20130310376-A1 2-ARYL-4-QUINAZOLINONES AND THEIR PHARMACEUTICAL COMPOSITIONS CCNE2, NFE2, NR2E1 PRKDC 4749/4885PIK3CD 3561/4885PIK3CB 4104/4885
US-20140018363-A1 2-ARYL-4-QUINAZOLINONES AND THEIR PHARMACEUTICAL COMPOSITIONS CCNE2, RB1, NR2E1 PRKDC 4740/4885PIK3CD 3738/4885PIK3CB 4024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback